Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST3GAL5 antisense RNA 1 (ST3GAL5-AS1) is a long non-coding RNA transcribed from the region antisense to the ST3GAL5 gene. Its precise biological function, disease association, or mechanistic role has not been established in peer-reviewed literature or major gene annotation databases. As an antisense lncRNA, it may have regulatory roles controlling the expression of the adjacent ST3GAL5 gene (which encodes lactosylceramide alpha-2,3-sialyltransferase, involved in ganglioside biosynthesis), but specific functions for the lncRNA itself remain to be elucidated. ST3GAL5-AS1 is distinct from the protein-coding ST3GAL5 (GM3 synthase) gene, which is an enzyme involved in ganglioside biosynthesis and is implicated in neurological disorders and some cancers, but the antisense RNA described here does not have documented direct involvement in known therapeutic pathways. No clear therapeutic target, receptor, enzyme, transporter, or drug interaction roles have been ascribed to ST3GAL5-AS1. ST3GAL5-AS1 is a long non-coding RNA associated with the ST3GAL5 gene locus, with no documented role as a therapeutic target or clinical biomarker, and lacking known drug interactions or clear biological functions based on current data.
Not applicable; no therapeutic targeting or known mechanisms related to drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST3GAL5 antisense RNA 1 (ST3GAL5-AS1).